By Conjoint Professor David goldstein

Journal articles

Brown RF; Butow PN; Sharrock MA; Henman M; Boyle F; Goldstein D; Tattersall MHN, 2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x

Hughes BGM; Yip D; Chao M; Gibbs P; Carroll S; Goldstein D; Burmeister B; Karapetis C, 2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x

Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G, 2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, 4, pp. 74, http://dx.doi.org/10.1186/1471-2407-4-74

Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384, http://dx.doi.org/10.1111/j.1468-1293.2004.00238.x

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100

Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia , 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508

Daly EB; Chen GW; Sun L; Friedlander ML; Goldstein D; Beer D; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, 19, pp. 170 - 172

Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MH, 2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, 22, pp. 1721 - 1730

Loi S; Goldstein D; Clezy KR; Milliken ST; Hoy JF; Chipman M, 2004, 'Castleman`s disease and HIV infection in Australia', HIV Medicine, 5, pp. 157 - 162

Qu XJ; Yang JL; Russell PJ; Goldstein D, 2004, 'Change in epidermal growth factor receptor expression in human bladdercancer cell lines following interferon-alpha treatment', Journal of Urology, 172, pp. 733 - 738

Apte MV; Wilson JS; Park S; Phillips PA; Santucci N; Goldstein D; Ramm GA; Buchler M; Friess H; Mccarroll JA; Merrett ND; Pirola RC, 2004, 'Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells', Pancreas, 29, pp. 179 - 187

Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695

Goldstein D; Carroll S; Apte M; Keogh G, 2004, 'Modern management of pancreatic carcinoma', INTERNAL MEDICINE JOURNAL, 34, pp. 475 - 481, http://dx.doi.org/10.1111/j.1444-0903.2004.00658.x

Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, 53, pp. 123 - 129

Jong KE; Smith DP; Yu XQ; O Connell DL; Goldstein D; Armstrong BK, 2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, 180, pp. 618 - 622

Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x

Shannon JF; Mackenzie-Wood AR; Wood G; Goldstein D, 2003, 'Cicatricial pemphigoid in non-Hodgkin`s lymphoma', Internal Medicine Journal, 33, pp. 396 - 397

Ngan SY; Fisher R; Burmeister B; Rischin D; Mackay J; Kneebone A; Joseph D; McKendrick J; Goldstein D; McClure B; Lim Joon D, 2003, 'Delayed relapse following preoperative chemoradiation and surgery for rectal cancer', International Journal of Radiation Oncology*Biology*Physics, 57, pp. S220 - S220, http://dx.doi.org/10.1016/s0360-3016(03)01035-6

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403

Eisenbruch IM; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, 59, pp. 235 - 248

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x

Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162

Goldstein D; Thewes B; Butow P, 2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, 32, pp. 289 - 296

Marx GM; Boyce A; Goldstein D, 2002, 'Elevated alpha-foetoprotein and hepatic metastases - it`s not always what it seems!', Annals of Oncology, 13, pp. 167 - 169

Harrison ML; Goldstein D, 2002, 'Prolonged survival in a patient with an occult small-cell lung cancer and a solitary brain metastasis at diagnosis', Internal Medicine Journal, 32, pp. 621 - 622

Goldstein D; Margo J, 2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, 25, pp. 121 - 125

Meiser B; Eisenbruch M; Barlow-Stewart K; Tucker K; Steel Z; Goldstein D, 2001, 'Cultural aspects of cancer genetics: setting a research agenda.', J Med Genet, 38, pp. 425 - 429, http://dx.doi.org/10.1136/jmg.38.7.425

Ngan S; Burmeister B; Fisher R; Rischin D; Schache D; Kneebone A; Mackay J; Joseph D; Bell A; Goldstein D, 2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, pp. 883 - 887

Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson GD; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, pp. 89 - 94

Herz H; Cooke B; Goldstein D, 2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525

Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; Mackay JR; Joseph DJ; Bell A; Goldstein D, 2000, 'A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology*Biology*Physics, 48, pp. 119 - 120, http://dx.doi.org/10.1016/s0360-3016(00)80035-8

Huang X; Butow PN; Meiser B; Goldstein D, 1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x

Bishop JF; Dewar J; Toner GC; Smith J; Tattersall MHN; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J; Canetta R, 1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, 17, pp. 2355 - 2364, http://dx.doi.org/10.1200/jco.1999.17.8.2355

Davis AJ; Goldstein D; Milliken S, 1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x

Newell ME; Milliken ST; Goldstein D; Lewis CR; Boyle MJ; Dolan G; Ryan S; Cooper DA; boyle , 1998, 'A phase 2 study of liposomal doxorubicin in the treatment of AIDS-related Kaposi¿s sarcoma', Australian and New Zealand Journal of Medicine, pp. 777 - 783

Goldstein D; Hertzog P; Tomkinson E; Couldwell D; Mccarville S; Parrish S; Cunningham PH; Newell ME; Owens M; Cooper DA, 1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, 178, pp. 856 - 861

Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', Oncology, 11, pp. 19 - 23

Bishop JF; Dewar J; Toner G; Tattersall MH; Olver I; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'A randomized study of paclitaxel versus cyclophosphamide/methotrexate/5-fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results', SEMINARS IN ONCOLOGY, 24, pp. 5 - 9

Goldstein D; Pillay P; Hayman J; Leydman M, 1997, 'Association of hypercalcaemia, PTHrP expression and disease progression in a woman with primary squamous cell carcinoma of the breast.', Pathologe, pp. 317 - 319

Goldstein D; Douglas JR; Penny R; Matthews JP; Laidlaw CR; Gibson K; Bradstock KF; Wolf M, 1997, 'Australian leukaemia study group myeloma II: A randomised trial of intensive combination chemotherapy with or without interferon in patients with myeloma.', British Journal Haematology, pp. 38 - 45

Joshua D; Penny R; Matthews JP; Laidlawcr ; Gibson K; Bradstock KF; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive comBination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, pp. 38 - 45

Goldstein D; Butow P; Tattersall MH, 1997, 'Communication with cancer patients in culturally diverse Societies.', Annals of the New York Academy of Sciences, pp. 317 - 329

Goldstein D; Wolley I; Collett J, 1997, 'Diffuse alveolar damage following a singel adminstration of a cyclophosphamide containing chemotherapy regimen.', Australian and New Zealand Journal of Medicine, pp. 605 - 606

Goldstein D; Bishop J; Dewar J; Tattersall MH; Smith JS; Olver IN; Ackland S; Kennedy I; Toner GC; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first line treatment for metastatic breast cancer.', Oncology, pp. 17 - 19

Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness', Annals of Oncology, pp. 871 - 875

Stricker P; Pryor K; Nicholson T; Goldstein D; Golovsky D; Ferguson R; Nash P; Ehsman S; Rumma J; Mammen G; Penny R, 1996, 'Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer', Urology, 48, pp. 957 - 962, http://dx.doi.org/10.1016/S0090-4295(96)00375-5

Millar JL; Goldstein D; Gelmon KA, 1996, '5.14 HIV and Kaposi's sarcoma', Medical Journal of Australia, 164, pp. 539 - 542, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122167.x

Boyle MJ; Goldstein DA; Frazer IH; Sculley TB, 1996, 'How HIV promotes malignancies', Medical Journal of Australia, 164, pp. 230 - 232, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94147.x

Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R; Rooney K; Mulligan S; Firkin F; Dodds A; Parkin J; Lowenthal R; Kimber R; Frost T; Grigg A; Goldstein D; Stone J; Lee N, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x

Goldstein D, 1996, 'HIV associated malignancies', Hematology Reviews and Communications, 9, pp. 275 - 283

Back to profile page